Τόμος 3 (1989) – Τεύχος 1 – Άρθρο 1 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 3 (1989) – Issue 1 – Article 1 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

2^nd Department of Cardiology, University of Thessaloniki, Greece

pharmakonpress[at]pharmakonpress[.]gr

2.         Maseri, A.: Variant angina and coronary vasospasm. Cardiovasc. Med. 4: 647 (1979).

3.         Cox, J.A.: Calcium calmodulin interaction and cellular functions. J. Cardiovasc. Pharmacol. 8: 548 (1986)

4.         Klee, C.B., Ni, W.-C., Draetta, J. et al.: Different modes of interaction of calmodulin with its target enzymes. J. Cardiovasc. Pharmacol. 8: 552 (1986)

5.         Adelstein, R.S., Eisenberg, E.: Regulation and kinetics of the actin-myosin-ATP interactions. Rev. Biochem. 49: 921 (1980)

6.         Marban, E., Rink, T.J., Tsien, R.W. et at.: Free calcium in heart muscle at rest and during contraction measured with Ca²⁺-sensitive microelectrodes. Nature 286: 845 (1980)

7.         Erne, P., Mittelholzer, E., Burgisser, E. et al.: Measurement of receptor induced changes in intracellular free calcium in human platelets. J. Recept. Res. 4(1-6): 587 (1984)

8.         Schultz, I.: Messenger role of calcium in function of pancreatic acinar cells. Am. J. Physiol. 239: 335 (1980)

9.         Hermsmeyer, Κ., Trapani, A., Abel, P.W.: Membrane-potential depedent tension in vascular muscle. In: Vasodilatation (P.M. Vanhoutte, I. Leusen, eds), p. 273, Raven, New York, 1981

10.       Johansson, B., Somlyo, A.P.: Electrophysiology and excitation-contraction coupling. In: Handbook of Physiology (D.F. Bohr et a I., eds), p. 301, 2^nd ed. Am. Physiol. Soc. Bethesda, 1980

11.       Saida, Κ., Van Breemen, C.: Cyclic AMP modulation of adrenoreceptor mediated arterial smooth muscle con-traction. J. Gen. Physio/. 84: 307 (1984)

12.       Berridge, M.J., lovine, R.F.: Inositol triphosphate, a novel second messenger in cellular signal transduction. Nature 312: 315 (1984)

13.       Fabiato, A., Fabiato, F.: Calcium and cardiac excitation contraction coupling. Am. Rev. Physiol. 41: 473 (1979)

14.       Hartshorne, D.J.: Biochemical basis for contraction of vascular smooth muscle. Chest 78: 140 (1980)

15.       Murphy, R.A., Askoy, M.D., Dillon, P.F. et al.: The role of myosin light chain phosphorylation in regulation of the crossbridge cycle. Fed. Proc. 42: 51 (1983)

16.       Schaub, M.C., Kunz, B.: Regulation of contraction in cardiac and smooth muscles. J. Carciovasc. Pharmacol. 8: S117 (1986)

17.       Carafoli, E., Crompton, M.: The regulation of intracellular calcium. Curr. Top. Membr. Transp. 10: 151 (1978)

18.       Somlyo, A.P., Somlyo, A.V.: Electron probe analysis of calcium content and movements in sarcoplasmic reticulum, endoplasmic reticulum, mitochondria and cytoplasm. J. Cardiovasc. Pharmacol. 8: S 42 (1986)

19.       Sevan, J.A.; Bevan, R.D., Hwa, H.H. et al.: Calcium regulation in vascular smooth muscle. Is there a pattern to its variability within the arterial tree? J. Cardiovasc. Pharmacol. 8: S 71 (1986)

20.       Fleckenstein, R.: Specific pharmacology of calcium in myocardium, cardiac pacemakers and vascular smooth muscle. Ann. Rev. Pharmacol. Toxicol. 17: 149 (1977)

21.       Kazazoglou, T., Schmid, A., Renaud, J.F., Lazdunski, M.: Ontogenic appearance of Ca²⁺ channels characterized as binding sites for nitrendepine during development of nervous, skeletal and cardiac muscle systems in the rat. FEBS ten. 164: 75 (1983)

22.       Fosset, M., Jaimovich, E., Delpont, E., Lazdunski, M.: [3H] nitrendepine receptors in skeletal muscles. J. Biol Chem. 258: 6086 (1983)

23.       Bolton, T.B.: Mechanisms of action of transmitters and other substances on smooth muscle. Physiol. Rev. 59: 606 (1979)

24.       Berridge. M.J.: Inositol triphosphate and calcium mobilization. J. Cardiovasc. Pharmacol. 8: 585 (1986)

25.       Carafoli, E.: Membrane transport in the cellular homeostasis of calcium. J. Cardiovasc. Pharmacol. 8: S 3 {1986)

26.       Helzmann, C.W.: Intracellular calcium-binding proteins. J. Cardiovasc. Pharmacol. 8: S 7 (1986)

27.       Bolton, T.B., Lang, R.J., Takewaki, T., Benham, C.D.: Patch and whole-cell voltage-clump studies on single smooth muscle cells. J. Cardiovasc. Pharmacol. 8: S 20 (1986)

28.       Baker, P.F.: Calcium pumps and electrogenesis. In: Physiology of Excitable Membranes, p. 127, Pergamon, 1981

29.       Blaustein, M.P., Nelson, M.T.: Sodium-calcium exchange. In: Membrane Transport of Calcium (E. Carafoli, ed.), p. 217, Academic Press, New York, 1982

30.       Schatzmann, H.J.: Calcium extrusion across the plasma membrane by the Ca², Na² exchange system. In: Calcium and the Cell Physiology (0. Marme, ed.), Springer, Berlin, New York, 1985

31.       Cavin, C., Lukeman, S., Cameron, J. et al.: Theoretical bases for vascular selectivity of Ca2+ antagonists. J. Cardiovasc. Pharmacol. 6: S 630 (1984)

32.       Jakobs, K.H., Watanabe, Y„ Baner, S.: Interactions between the hormone-sensitive adenylate cyclase system and the phosphoinositide-metabolizing pathway in human platelets. J. Cardiovasc. Pharmacol. 8: S 61 (1986)

33.       Murad, F„ Waldman, S.A., Fiscus, R.R., Rapoport, R.M.: Regulation of cyclic GMP synthesis and the interactions with calcium. J. Cardiovasc. Pharmacol. 8: S 57 (1986)

34.       Langer, S.Z., Hicks, P.E.: Alpha-adrenoceptor subtypes in blood vessels. J. Cardiovasc. Pharmacol. 6: S 547 (1984)

35.       Kobinger, W., Pichler, L: α1 and α2 adrenoceptor subtypes. Ear. J. Pharmacol. 73: 313 (1981)

36.       Lefkowitz, R.J., Stadel, J.M., .Caron, M.G.: Adenylate cyclase-coupled beta-adrenergic receptors. Ann. Rev. Biochem. 52: 159 (1983)

37.       Katusic, Z.S., Vanhoutte, P.: Anoxic contractions in isolated canine cerebral arteries: Contribution of endothelium-derived factors, metabolites of arachidonic acid, and calcium entry. J. Cardiovasc. Pharmacol. 8: S 97 (1986)

38.       Aiken, J.W.: Prostaglandins. J. Cardiovasc. Pharmacol. 6: S 413 (1984)

39.       Furchgott, R.F., Cherry, P.D., Zawadjki, J.W., Jothianandan, D.: Endothelial cells as mediators of vasodilation of arteries. J. Cardiovasc. Pharmacol. 9: S 336 (1987)

40.       Langer, S.Z.: Presynaptic regulation of the release of catecholamines. Pharmacol. Rev. 32: 337 (1981)

41.       Marshall, I.: Characterization and distribution of histamine H, and H2-receptors in precapillary vessels. J. Cardiovasc. Pharmacol. 6: S 587 (1984)

42.       Ragoli, D.: Neurochumoral regulation of precapillary vessels: The Kallikrein-kinin system. J. Carciovasc. Pharmacol. 6: S 401 (1984)

43.       Berkowitz, B.A.: Dopamine and dopamine receptors as target sites for cardiovascular drug action. Fed. Proc. 42: 3019 (1983)

44.       Kreye, V.A.W.: Direct vasodilators with unknown modes of action. The nitro-compounds and hydralazine. J. Cardiovasc. Pharmacol. 6: S 646 (1984)

45.       Alabaster, V., Daren: Precapillary vessels: Effects of the sympathetic nervous system and of catecholamines. J. Cardiovasc. Pharmacol. 6: S 365 (1984)

46.       Capponi, A.M., Aquilera, G., Fakunding, J.L., Catt, K.J.: Angiotensin II receptors and mechanisms of action. In: Biochemical Regulation of Blood Pressure (R.L. Soffer, ed.), p. 205, J. Wiley and Sons, New York, 1981

47.       Hardman, J.G.: Cyclic nucleotides and regulation of vascular smooth muscle. J. Cardiovasc. Pharmacol. 6: S 639 (1984)

48.       Katada, T., Bokoch, G.M., Northup, J.K., Gilman, A.G.: Guanine nucleotide and/or hormone-induced inhibition of adenylate cyclase. Fed. Proc. 42: 1850 (1983)

49.       Lefkowitz, R.J., Stadel, J.M., Caron, M.G.: Adenylate cyclase-coupied beta-adrenergic receptors. Ann. Rev. Biochem. 52: 159 (1983)

50.       Berkowitz, B.A., Ohlstein, E.H.: Cardiovascular dopamine receptors. J. Carciovasc. Pharmacol. 6: S 559 (1984)

51.       Regoli, D., Barable, J., Park, W.K.: Receptors for bra- dykinin in rabbit aortae. Can. J. Physiol. Pharmacol. 55: 855 (1977)

52.       Glossmann, H., Ferry, D.R. et al.: Molecular Pharmacology of the calcium channel: Evidence for subtypes, multiple drug receptor sites, channel subunits and the development of 2 radioiodinated 1,4-dihydropyridine calcium channel label [2Sl] iodipine. J. Cardiovasc. Pharmacol. 6: S 608 (1984)

53.       Johnson, P.C.: Autoregulation of blood flow. Circ. Res. 59: 483 (1986)

54.       Schrader, J., Gerlach, E.: Compartmentation of cardiac adenine nucleotides and formation of adenosine. Pflugers Arch. 367: 129 (1976)

55.       Miller, W.L., Belardinelli, L., Bacchus, A. et al.: Canine myocardial adenosine and lactate production, oxygen consumption and coronary blood flow during stellate ganglia stimulation. Circ. Res. 45: 708 (1979)

56.       Manfredi, J.P., Sparks, H.V.: Adenosine’s role in coronary vasodilation induced by arterial pacing and norepinephrine. Am. J. Physiol. 243: H 536 (1982)

57.       Holtz, J., Giester, M., Bassenge, E.: Two dilatory mechanisms of anti-anginal drugs on epicardiac coronary arteries in vivo: indirect, flow-dependent, endothe1 liummediated dilation and direct smooth muscle relaxation. Zeit. Kardiof. 72 (suppl. 3): 98 (1983)

’58. Gerova, M., Gero, J., Barta, E. et al.: Neurogenic and myogenic control of conduit coronary arteries. Basic. Res. Cardiol. 76: 503 (1981)

59.       Olsson, R.A., Snow, J.A., Gentry, M.K.: Adenosine metabolism in canine myocardial reactive hyperemia. Proc. Soc. Exp. Biol. Med. 141: 593 (1972)

60.       Saito, D., Seinhart, C.R., Nixon, D.G., Olsson, R.A.: Intracoronary adenosine deaminase reduces canine myocardial reactive hyperemia. Circ. Res. 49: 1262 (1981)

61.       Samuelsson, B., Paoletti, R. (eds): Leukotrienes and other lipoxygenase products. A dr. Prostaglandin Thromboxane Leukotriene Res. 9: -(1982)

62.       Guyton, R.A., McClenathan, J.H., Michaelis, L.L.: Evo- luation of regional ischemia distal to a proximal coronary stenosis. Am, J. Cardiol. 40: 381 (1977)

63.       Sparks, H.V., Gorman, M.G.: Ischemic vasodilation or ischemic vasoconstriction. In: Vasodilation (P.M. Vanhoutte, I. Leusen, eds), p. 193, New York, Raven, 1981

64.       Hamilton, F.N., Feigl, E.O.: Coronary vascular sympathetic beta-receptor innervation. Am. J. Physiol. 230: 1569 (1976)

65.       Yasue, H., Touyama, M., Shimamoto, M. et al.: Role of autonomic nervous system in the pathogenesis of Prinzmetal’s variant form of angina. Circulation 50: 53.4 (1974)

66.       Yasue, H., Touyama, M., Kato, H. et al.: Prinzmetal’s variant form of angina as a manifestation of alpha adrenergic receptor-mediated coronary artery spasm: documentation by coronary arteriography. Am. Heart J. 91: 148 (1976)

67.       Levene, D.L., Freeman, M.R.: Alpha-adrenergic mediated coronary artery spasm. J.A.M.A. 236: ,1018 (1976)

68.       Lang, R.E., Taugner, G., Gaida, W. et al.: Evidence against co-storage of enkephalins with noradrenaline in bovine adrenal medullary granules. Eur. J. Pharmacol. 86: 117 (1983)

69.       Wilson, S.P., Klein, R.L, Change, K.J. et al.: Are opioid peptides contransmitters in noradrenergic vesicle of sympathetic nerves? Nature 288: 707 (1980)

70.       Gaddis, R.R., Dixon, W.R.: Presynaptic opiate receptor- mediated inhibition of endogenous norepinephrine and dopamine-beta hydroxylase release in the cat spleen, independent of the presynaptic alpha-adrenoreceptors. J. Pharmacol. Exp. Ther. 223: 77 (1982)

71.       Ganten, D., Lang, R.E., Archelos, J., Unger, T.H.: Peptidergic systems. J. Cardiovasc. Pharmacol. 6: S 598 (1984)

72.       Slezer, A., Langston, M. et al.: Clinical syndrome of variant angina with normal coronary arteriogram. N. Engl. J. Med. 295: 1343 (1976)

73.       MacAlpin, R.N.: Contribution of dynamic vascular wall thickening to luminal narrowing during coronary arterial contriction. Circulation 61: 296 (1980)

74.       Chierchia, S., Davies, G., Gerkenboom, G. et al.: Alpha-adrenergic receptors and coronary spasm. Circulation 69: 8 (1984)

75.       Ainsburg, R., Bristow, M.R., Kantrowitz, N. et a I.: Histamine provocation of clinical coronary artery spasm. Am. Heart J. 102: 819 (1981)

76.       Shimokawa, H., Tomoike, H., Nakeyama, S. et al.: Coronary artery spasm induced in atherosclerotic miniature swine. Science .221:’ 560 (1983)

77.       Endo, M„ Hirosawa, K. (Kaneko, N. et al.: Prinzmetal’s variant angina. N. Engl. J. Med. 294: 252 (1976)

78.       Frank, G.W., Bevan, J.A.: Electrical stimulation causes endothelium-dependent relaxation in lung vessels. Am. J. Physiol. 244: H 793 (1983)

79.       Lang, R.L., Reid, M.S., Tresch, D.D. et al.: Nonatheromatous ischemic heart disease following withdrawal from chronic industrial, nitroglycerine exposure. Circulation 46: 666 (1972)

80.       Yasue, H., Nagao, M., Omote, S. et al.: Coronary arterial spasm and Prinzmetal’s variant form of angina induced byhyperventilation and tris-buffer infusion. Circulation 58: 56 (1978)

81.       Turlapaty, P.D.M.V., Altura, B.M.: Magnesium deficiency produces spasms of coronary arteries. Science 208. 198 (1980)

S2.       Martin, T.J., Smith, I.L., Nolan, R.D., Dusting, G.-J.:- Prostanoids in platelet-vascular interactions. Am. J. Cardiol. 52: 22A (1983)

83: Furchgott, R.F., Zawadzki, J.V.: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373 (1980)

84.       Chand, N., Altura, B.M.: Acetylcholine and bradyktnine relax in trapulmonary arteries by acting on endothelial cells. Science 217: 1376 (1981)

85.       Ku, D.D.: Coronary vascular reactivity after acute myocardial ischemia. Science 218: 576 (1982)

86.       Van Nuetan, J.M., Jansen, P.A.J., Van Beek, J. et al.: Vascular effects of ketanserin a novel antagonist of 5-HT2 serotonergic receptors. J. Pharmacol. Exp. Ther. 218: 217 (1981)

87.       Yokoyama, M„ Henry, P.D.: Sensitization of isolated canine coronary arteries to calcium ions after exposure to cholesterol. Circ. Res. 45: 479 (1979)

88.       Shattif, S.J., Anaya-Galindo, R., Bennett, J. et al.: Platelet hypersensitivity induced by cholesterol incorporation. J. Clin. Invest. 55: 636 (1975)

89.       Henry, P.D., Yokoyama, M.: Supersensitivity of atherosclerotic rabbit aorta to ergonovine. J. Clin. Invest. 66: 306 (1980)

pharmakonpress[at]pharmakonpress[.]gr

pharmakonpress[at]pharmakonpress[.]gr